SANGAMO THERAPEUTICS, INC Logo

SANGAMO THERAPEUTICS, INC

A clinical-stage genomic medicine company developing therapies for severe diseases.

SGMO | US

Overview

Corporate Details

ISIN(s):
US8006771062
LEI:
Country:
United States of America
Address:
501 CANAL BLVD., 94084 RICHMOND

Description

Sangamo Therapeutics, Inc. is a clinical-stage genomic medicine company focused on translating groundbreaking science into medicines for patients with severe diseases. The company utilizes its proprietary zinc finger (ZFN) technology platform to develop a pipeline of genomic therapies. Its research and development efforts are concentrated on creating potential cures and treatments for a range of conditions, including neurological disorders, autoimmune diseases, and oncology. Sangamo aims to address the underlying genetic causes of diseases where current medical options primarily offer symptom management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 22:10 English 7.9 KB
2025-11-26 22:09 English 7.9 KB
2025-11-26 22:08 English 8.0 KB
2025-11-26 22:07 English 7.9 KB
2025-11-26 22:06 English 8.0 KB
2025-11-26 22:05 English 7.9 KB
2025-11-12 20:34 English 8.0 KB
2025-11-06 14:07
10-Q
English 1.4 MB
2025-11-06 14:05
8-K
English 190.7 KB
2025-10-29 21:08
8-K
English 60.0 KB
2025-10-24 23:00 English 8.0 KB
2025-10-24 23:00 English 7.8 KB
2025-10-24 23:00 English 7.9 KB
2025-10-24 23:00 English 7.9 KB
2025-10-24 23:00 English 7.9 KB

Automate Your Workflow. Get a real-time feed of all SANGAMO THERAPEUTICS, INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANGAMO THERAPEUTICS, INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANGAMO THERAPEUTICS, INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.